AAAAAA
Results:
1-7
|
Results: 7
Authors:
Zhou, JX
Niehans, GA
Shar, A
Rubins, JB
Frizelle, SP
Kratzke, RA
Citation: Jx. Zhou et al., Mechanisms of G(1) checkpoint loss in resected early stage non-small cell lung cancer, LUNG CANC, 32(1), 2001, pp. 27-38
Authors:
Rubins, JB
Charboneau, D
Alter, MD
Bitterman, PB
Kratzke, RA
Citation: Jb. Rubins et al., Inhibition of mesothelioma cell growth in vitro by doxycycline, J LA CL MED, 138(2), 2001, pp. 101-106
Authors:
Frizelle, SP
Rubins, JB
Zhou, JX
Curiel, DT
Kratzke, RA
Citation: Sp. Frizelle et al., Gene therapy of established mesothelioma xenografts with recombinant p16(INK4a) adenovirus, CANC GENE T, 7(11), 2000, pp. 1421-1425
Authors:
Bernini, A
Spencer, M
Frizelle, S
Madoff, RD
Willmott, LD
McCormick, SR
Niehans, GA
Ho, SB
Kratzke, RA
Citation: A. Bernini et al., Evidence for colorectal cancer micrometastases using reverse transcriptase-polymerase chain reaction analysis of MUC2 in lymph nodes, CANCER DET, 24(1), 2000, pp. 72-79
Authors:
Gupta, P
Niehans, GA
LeRoy, SC
Gupta, K
Morrison, VA
Schultz, C
Knapp, DJ
Kratzke, RA
Citation: P. Gupta et al., Fas ligand expression in the bone marrow in myelodysplastic syndromes correlates with FAB subtype and anemia, and predicts survival, LEUKEMIA, 13(1), 1999, pp. 44-53
Authors:
Lickliter, JD
Kratzke, RA
Nguyen, PL
Niehans, GA
Miller, JS
Citation: Jd. Lickliter et al., Fas ligand is highly expressed in acute leukemia and during the transformation of chronic myeloid leukemia to blast crisis, EXP HEMATOL, 27(10), 1999, pp. 1519-1527
Authors:
Niehans, GA
Kratzke, RA
Froberg, MK
Aeppli, DM
Nguyen, PL
Geradts, J
Citation: Ga. Niehans et al., G1 checkpoint protein and p53 abnormalities occur in most invasive transitional cell carcinomas of the urinary bladder, BR J CANC, 80(8), 1999, pp. 1175-1184
Risultati:
1-7
|